What is a healthy triglyceride level by age?

Healthy triglyceride levels are below 150 mg/dL for adults, with optimal levels under 100 mg/dL, though children have lower targets. Regular testing helps track cardiovascular risk since triglycerides naturally increase with age.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Triglycerides and Their Role in Your Health

Triglycerides are the most common type of fat in your body, serving as a crucial energy source between meals. When you eat, your body converts excess calories into triglycerides and stores them in fat cells. Later, hormones release these triglycerides to provide energy when needed. While this process is normal and necessary, consistently high triglyceride levels can signal metabolic problems and increase your risk of heart disease, stroke, and pancreatitis.

Unlike cholesterol, which your body uses to build cells and produce hormones, triglycerides function purely as an energy storage mechanism. However, both are lipids that travel through your bloodstream in packages called lipoproteins, and both can contribute to the buildup of plaque in your arteries when levels are too high. Understanding your triglyceride levels across different life stages helps you maintain optimal cardiovascular health and prevent future complications.

Healthy Triglyceride Ranges for Adults

For adults aged 20 and older, the National Cholesterol Education Program provides standardized triglyceride level classifications that healthcare providers use to assess cardiovascular risk. These ranges apply to both men and women, though individual factors like genetics, lifestyle, and other health conditions can influence what's optimal for each person.

Adult Triglyceride Level Classifications

Triglyceride LevelClassificationHealth ImplicationsRecommended Actions
Below 100 mg/dLBelow 100 mg/dLOptimalLowest cardiovascular riskMaintain healthy lifestyle
100-149 mg/dL100-149 mg/dLNormalAcceptable risk levelMonitor annually, optimize diet
150-199 mg/dL150-199 mg/dLBorderline HighIncreased heart disease riskLifestyle changes recommended
200-499 mg/dL200-499 mg/dLHighSignificant cardiovascular riskMedical evaluation, possible medication
500+ mg/dL500+ mg/dLVery HighRisk of pancreatitisImmediate medical treatment required

Based on National Cholesterol Education Program guidelines. Individual targets may vary based on overall cardiovascular risk profile.

The American Heart Association recommends aiming for triglyceride levels below 100 mg/dL for optimal heart health, which is lower than the standard 'normal' cutoff of 150 mg/dL. This more aggressive target reflects growing evidence that even moderately elevated triglycerides can contribute to cardiovascular disease, especially when combined with other risk factors like low HDL cholesterol or high blood pressure.

It's important to note that triglyceride levels can fluctuate significantly based on recent meals, alcohol consumption, and physical activity. For the most accurate reading, you should fast for 9-12 hours before testing. Some people may see their triglycerides spike to over 400 mg/dL after a fatty meal, which is why standardized fasting measurements provide the most reliable baseline for monitoring your cardiovascular health. Regular monitoring through comprehensive lipid panels helps track your progress and adjust treatment strategies as needed.

Triglyceride Levels in Children and Adolescents

Children and teenagers have different triglyceride targets than adults, with lower thresholds for what's considered healthy. The American Academy of Pediatrics recommends universal lipid screening for all children between ages 9-11 and again between ages 17-21. For children and adolescents aged 10-19, triglyceride levels should ideally stay below 90 mg/dL, with levels above 130 mg/dL considered high.

Younger children (ages 0-9) should have even lower triglyceride levels, typically below 75 mg/dL. These lower targets reflect the fact that atherosclerosis begins in childhood, and early intervention can prevent cardiovascular disease later in life. Children with family histories of high cholesterol, heart disease, or diabetes may need earlier and more frequent screening.

Risk Factors in Young People

Several factors can contribute to elevated triglycerides in children and teens, including obesity, sedentary lifestyle, diets high in processed foods and sugary drinks, and genetic conditions like familial hypertriglyceridemia. The rise in childhood obesity has led to more young people developing metabolic syndrome, a cluster of conditions that includes high triglycerides, low HDL cholesterol, high blood pressure, and insulin resistance.

How Triglyceride Levels Change with Age

Triglyceride levels naturally tend to increase as we age, with several physiological and lifestyle factors contributing to this trend. During young adulthood (20s-30s), triglycerides often remain relatively stable if healthy habits are maintained. However, metabolism begins to slow in the 30s and 40s, making it easier to gain weight and harder to maintain optimal lipid levels.

Middle age (40s-60s) often brings the highest triglyceride levels, particularly in men. This increase coincides with decreased physical activity, hormonal changes, and the accumulation of visceral fat around the midsection. Women may see a significant rise in triglycerides after menopause due to declining estrogen levels, which previously provided some cardiovascular protection.

Triglycerides in Older Adults

Interestingly, triglyceride levels may plateau or even decrease slightly in adults over 70, though this doesn't necessarily indicate improved health. This phenomenon can result from changes in diet, decreased appetite, muscle loss, or underlying health conditions. Older adults should continue monitoring their triglycerides as part of comprehensive cardiovascular risk assessment, as the relationship between triglycerides and heart disease remains significant throughout life.

Gender Differences in Triglyceride Levels

Men and women exhibit distinct patterns in triglyceride levels throughout their lives. Before menopause, women typically have lower triglyceride levels than men of the same age, partly due to the protective effects of estrogen. However, women's triglycerides often increase more dramatically after menopause, sometimes surpassing those of age-matched men.

During pregnancy, women experience naturally elevated triglycerides, particularly in the second and third trimesters, as the body adapts to support fetal development. These levels usually return to normal after delivery, but women with gestational diabetes or excessive weight gain during pregnancy may maintain higher triglycerides postpartum. Hormonal contraceptives and hormone replacement therapy can also affect triglyceride levels, making regular monitoring important for women using these medications.

Testing and Monitoring Your Triglycerides

Regular triglyceride testing is essential for maintaining cardiovascular health, especially as you age or if you have risk factors like diabetes, obesity, or family history of heart disease. The standard lipid panel measures triglycerides along with total cholesterol, LDL cholesterol, and HDL cholesterol, providing a comprehensive picture of your cardiovascular risk profile.

Most adults should have their triglycerides checked every 4-6 years starting at age 20, though those with risk factors may need annual testing. If you're actively working to lower your triglycerides through lifestyle changes or medication, your healthcare provider may recommend testing every 3-6 months to track progress. Advanced lipid testing can provide additional insights, including particle size and apolipoprotein levels, which offer a more nuanced view of cardiovascular risk.

Interpreting Your Results

When reviewing your triglyceride results, consider them in context with your other lipid values and overall health picture. The triglyceride-to-HDL ratio is particularly informative, with a ratio above 3.5 suggesting insulin resistance and increased cardiovascular risk. Non-fasting triglyceride levels are also gaining recognition as potentially better predictors of heart disease risk, as they reflect your body's ability to clear fats after meals.

Lifestyle Strategies to Maintain Healthy Triglycerides

Managing triglycerides effectively often starts with dietary modifications. Reducing intake of refined carbohydrates and added sugars can lead to significant improvements, as these foods rapidly convert to triglycerides in the liver. Focus on whole grains, lean proteins, and healthy fats from sources like olive oil, nuts, and fatty fish. The Mediterranean diet pattern has shown particular success in lowering triglycerides while improving overall cardiovascular health.

Regular physical activity is equally important for triglyceride management. Aim for at least 150 minutes of moderate-intensity exercise weekly, as aerobic activity helps your muscles use triglycerides for fuel and improves insulin sensitivity. Even modest weight loss of 5-10% can reduce triglycerides by 20% or more. Limiting alcohol intake is crucial, as alcohol can dramatically increase triglyceride production in the liver, especially in sensitive individuals.

Supplements and Natural Approaches

Several supplements have shown promise in managing triglycerides. Omega-3 fatty acids from fish oil can reduce triglycerides by 20-30% at therapeutic doses of 2-4 grams daily. Niacin (vitamin B3) can also lower triglycerides while raising HDL cholesterol, though it should be used under medical supervision due to potential side effects. Soluble fiber supplements, green tea extract, and garlic have shown modest benefits in some studies.

When Medical Treatment Becomes Necessary

While lifestyle modifications form the foundation of triglyceride management, some people require medication to achieve healthy levels. Treatment is typically recommended when triglycerides exceed 500 mg/dL due to the risk of pancreatitis, or when levels remain above 200 mg/dL despite lifestyle changes, especially with other cardiovascular risk factors present.

The choice of medication depends on your overall lipid profile and health conditions. Statins primarily lower LDL cholesterol but can reduce triglycerides by 10-30%. Fibrates specifically target triglycerides and can achieve 30-50% reductions. Prescription omega-3 fatty acids and newer medications like PCSK9 inhibitors offer additional options for those who don't respond adequately to first-line treatments. Your healthcare provider will consider factors like kidney function, liver health, and potential drug interactions when selecting the most appropriate therapy.

Taking Control of Your Triglyceride Health

Understanding and managing your triglyceride levels throughout life is a crucial component of cardiovascular health. While age-related changes are normal, they don't have to be inevitable. By staying informed about healthy ranges for your age group, getting regular testing, and implementing appropriate lifestyle modifications, you can maintain optimal triglyceride levels and reduce your risk of heart disease and other complications.

Remember that triglycerides are just one piece of the cardiovascular puzzle. Work with your healthcare provider to develop a comprehensive approach that addresses all aspects of your metabolic health, including blood pressure, blood sugar, and other lipid markers. With the right knowledge and tools, you can take proactive steps to protect your heart health at any age.

References

  1. Miller M, Stone NJ, Ballantyne C, et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2011;123(20):2292-2333.[Link][PubMed][DOI]
  2. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128(Suppl 5):S213-S256.[Link][PubMed][DOI]
  3. Nordestgaard BG. Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology. Circ Res. 2016;118(4):547-563.[Link][PubMed][DOI]
  4. Berglund L, Brunzell JD, Goldberg AC, et al. Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(9):2969-2989.[Link][PubMed][DOI]
  5. Jacobson TA, Ito MK, Maki KC, et al. National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 - executive summary. J Clin Lipidol. 2014;8(5):473-488.[Link][PubMed][DOI]
  6. Sandesara PB, Virani SS, Fazio S, Shapiro MD. The forgotten lipids: triglycerides, remnant cholesterol, and atherosclerotic cardiovascular disease risk. Endocr Rev. 2019;40(2):537-557.[Link][PubMed][DOI]

Frequently Asked Questions

How can I test my triglycerides at home?

You can test your triglycerides at home with SiPhox Health's Heart & Metabolic Program, which includes triglycerides testing along with other essential cardiovascular biomarkers. The program offers convenient at-home blood collection with lab-quality results.

What is the normal triglyceride range for a 50-year-old?

For adults of any age, including 50-year-olds, normal triglycerides are below 150 mg/dL, though optimal levels are under 100 mg/dL. People in their 50s often see higher levels due to slower metabolism and hormonal changes, making regular monitoring especially important.

How quickly can triglyceride levels change?

Triglyceride levels can change within weeks with lifestyle modifications. Diet changes typically show results in 2-4 weeks, while adding regular exercise can reduce levels by 20-30% within 8-12 weeks. Medication effects are often seen within 4-6 weeks.

Do I need to fast before a triglyceride test?

Yes, fasting for 9-12 hours before testing provides the most accurate baseline triglyceride measurement. Recent meals, especially those high in fat or carbohydrates, can cause temporary spikes that don't reflect your true baseline levels.

Can triglycerides be too low?

While rare, extremely low triglycerides (below 40 mg/dL) can occur with hyperthyroidism, malnutrition, or certain genetic conditions. Most people should focus on avoiding high levels rather than worrying about levels being too low.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details